Physical activity is associated with lower insulin and C-peptide during glucose challenge in children and adolescents with family background of diabetes.


Journal

Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858

Informations de publication

Date de publication:
03 2019
Historique:
accepted: 19 09 2018
pubmed: 23 9 2018
medline: 21 1 2020
entrez: 23 9 2018
Statut: ppublish

Résumé

Children and adolescents with a family history of diabetes are at increased risk of overweight, but little is known about the potentially beneficial effects of physical activity on these children. The objective of this study was to investigate the association between moderate to vigorous physical activity (MVPA) and metabolic and inflammatory risks in children and adolescents with a family background of Type 1 diabetes or gestational diabetes. Valid MVPA measurements, made with accelerometers, were available from 234 participants (median age, 10.2 years) who had a first-degree relative with either Type 1 or gestational diabetes. Anthropometric and metabolic measurements were made and cytokines measured, and were correlated with MVPA measurements, with stepwise adjustment for confounding factors, in a cross-sectional analysis. MVPA was negatively associated with insulin and C-peptide during challenge with an oral glucose tolerance test. MVPA was also significantly positively associated with the insulin sensitivity index, whereas no consistently significant associations were found between MVPA and BMI, blood pressure or cytokine levels. Our findings indicate that physical activity may have beneficial effects on insulin and C-peptide metabolism in children and adolescents with a family background of diabetes, but show no evidence of a protective association with other health-related outcomes.

Identifiants

pubmed: 30242901
doi: 10.1111/dme.13819
doi:

Substances chimiques

C-Peptide 0
Insulin 0
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

366-375

Informations de copyright

© 2018 Diabetes UK.

Auteurs

K Ungethüm (K)

Institute of Diabetes Research, Helmholtz Zentrum München, Neuherberg and Forschergruppe Diabetes der Technischen Universität München, Munich.

M Jolink (M)

Institute of Diabetes Research, Helmholtz Zentrum München, Neuherberg and Forschergruppe Diabetes der Technischen Universität München, Munich.

M Hippich (M)

Institute of Diabetes Research, Helmholtz Zentrum München, Neuherberg and Forschergruppe Diabetes der Technischen Universität München, Munich.

L Lachmann (L)

Institute of Diabetes Research, Helmholtz Zentrum München, Neuherberg and Forschergruppe Diabetes der Technischen Universität München, Munich.

F Haupt (F)

Institute of Diabetes Research, Helmholtz Zentrum München, Neuherberg and Forschergruppe Diabetes der Technischen Universität München, Munich.

C Winkler (C)

Institute of Diabetes Research, Helmholtz Zentrum München, Neuherberg and Forschergruppe Diabetes der Technischen Universität München, Munich.
Forschergruppe Diabetes e.V. am Helmholtz Zentrum München, Neuherberg.

S Hummel (S)

Institute of Diabetes Research, Helmholtz Zentrum München, Neuherberg and Forschergruppe Diabetes der Technischen Universität München, Munich.
Forschergruppe Diabetes e.V. am Helmholtz Zentrum München, Neuherberg.

A Pitchika (A)

Institute of Diabetes Research, Helmholtz Zentrum München, Neuherberg and Forschergruppe Diabetes der Technischen Universität München, Munich.

O Kordonouri (O)

Kinder- und Jugendkrankenhaus AUF DER BULT, Hannover, Germany.

A-G Ziegler (AG)

Institute of Diabetes Research, Helmholtz Zentrum München, Neuherberg and Forschergruppe Diabetes der Technischen Universität München, Munich.
Forschergruppe Diabetes e.V. am Helmholtz Zentrum München, Neuherberg.

A Beyerlein (A)

Institute of Diabetes Research, Helmholtz Zentrum München, Neuherberg and Forschergruppe Diabetes der Technischen Universität München, Munich.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH